See also this year's filing and all EDGAR filings for this company.
PDF Report 0001815974_2025_Anebulo_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001815974, Anebulo Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,507,990 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 565,124 |
| 4 | LiabilitiesCurrent | 156,426 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 104,157 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,663,690 |
| 9 | ResearchAndDevelopmentExpense | 3,832,262 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 87,898 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,073,114 |
| 1 | Liabilities | 260,583 |
| 2 | Expenses | 7,495,952 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,812,531 |
| 5 | NetIncome | -7,408,054 |
| 6 | ComprehensiveNetIncome | -7,408,054 |
| 7 | BaseVar | 5,958,774 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.417 |
| 9 | EconomicCapitalRatio | 1.81 |